About Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome
Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome is a rare disease catalogued by Orphanet (ORPHA:494439). It is associated with the EXOSC2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome trials.
Search ClinicalTrials.gov for "Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome" or filter by Orphanet code ORPHA:494439 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome. Updated daily.